Revised Cardiac Risk Index (RCRI)

Learn about the Revised Cardiac Risk Index (RCRI) for estimating perioperative cardiac risk in non-cardiac surgery. Explore predictors, scoring system, interpretation, clinical use, and limitations.

Revised Cardiac Risk Index (RCRI) Calculator

Select all risk factors that apply. The RCRI estimates the risk of major cardiac events (cardiac death, nonfatal MI, nonfatal cardiac arrest) in patients undergoing elective major noncardiac surgery.

Risk factors

Disclaimer: The RCRI is an educational clinical decision-support tool. It does not replace comprehensive preoperative assessment, patient-specific risk-benefit discussions, or clinical judgment. Perioperative cardiac risk management should incorporate all relevant clinical findings, patient comorbidities, surgical urgency, and institutional protocols. Always consult cardiology when clinically indicated.

RCRI: formula, variables, and clinical context

Overview

The Revised Cardiac Risk Index (RCRI), also known as the Lee Index, is a validated preoperative risk stratification tool that estimates the probability of major cardiac events (cardiac death, nonfatal myocardial infarction, and nonfatal cardiac arrest) in patients undergoing elective major noncardiac surgery. Developed by Lee et al. in 1999 as a simplification of the original Goldman Index, the RCRI has become one of the most widely used cardiac risk assessment tools in perioperative medicine and is incorporated into the ACC/AHA perioperative cardiovascular evaluation guidelines.

Formula

The RCRI is an additive score. Each of the six risk factors present adds 1 point to the total. The sum (0 to 6) maps to an estimated probability of major cardiac complications.

RCRI Score = (High-risk surgery) + (Ischemic heart disease) + (CHF) + (Cerebrovascular disease) + (Insulin-dependent DM) + (Creatinine > 2 mg/dL)

Each variable = 1 if present, 0 if absent. Range: 0 to 6.

Scoring variables

Risk Factor	Definition	Points
High-risk surgery	Intraperitoneal, intrathoracic, or suprainguinal vascular	+1
Ischemic heart disease	History of MI, positive exercise test, current ischemic chest pain, nitrate use, or pathological Q waves on ECG	+1
Congestive heart failure	History of pulmonary edema, bilateral rales or S3, PND, or CXR with pulmonary vascular redistribution	+1
Cerebrovascular disease	History of stroke (CVA) or transient ischemic attack (TIA)	+1
Insulin-dependent diabetes	Preoperative insulin therapy for diabetes mellitus	+1
Creatinine > 2 mg/dL	Preoperative serum creatinine > 2 mg/dL (177 µmol/L)	+1
Total score range		0-6

Risk stratification

RCRI Score	Risk category	Estimated risk of major cardiac event
0	Very low risk	3.9%
1	Low risk	6.0%
2	Elevated risk	10.1%
≥ 3	High risk	≥ 15%

Risk percentages represent the estimated rate of major cardiac events: cardiac death, nonfatal myocardial infarction, and nonfatal cardiac arrest. Derived from the original validation cohort (n = 1,422).

Variable definitions

High-risk surgery

Intraperitoneal (e.g., bowel resection, cholecystectomy via laparotomy), intrathoracic (e.g., lobectomy, esophagectomy), or suprainguinal vascular (e.g., aortic aneurysm repair, aortobifemoral bypass) procedures. These surgeries are associated with greater hemodynamic stress, larger fluid shifts, and higher potential for significant blood loss compared to superficial or infrainguinal procedures.

Ischemic heart disease

Defined by any of the following: history of myocardial infarction, history of a positive exercise stress test, current complaint of ischemic chest pain or angina, use of sublingual nitroglycerin, or resting ECG demonstrating pathological Q waves. This criterion captures patients with known or suspected coronary artery disease who are at heightened risk for perioperative myocardial ischemia.

Congestive heart failure

Defined by any of the following: history of congestive heart failure, history of pulmonary edema, paroxysmal nocturnal dyspnea (PND), physical examination demonstrating bilateral rales or an S3 gallop, or chest radiograph showing pulmonary vascular redistribution (cephalization of flow). Both systolic and diastolic heart failure qualify.

Cerebrovascular disease

History of stroke (ischemic or hemorrhagic cerebrovascular accident) or transient ischemic attack (TIA). This criterion identifies patients with systemic atherosclerotic disease who may also harbor significant coronary artery disease.

Insulin-dependent diabetes mellitus

Diabetes mellitus treated with insulin preoperatively. Patients on diet control alone or oral hypoglycemic agents alone do not meet this criterion. Insulin dependence serves as a proxy for more advanced or less well-controlled disease, which is associated with a higher burden of microvascular and macrovascular complications, including silent myocardial ischemia.

Preoperative creatinine > 2 mg/dL (177 µmol/L)

A serum creatinine greater than 2.0 mg/dL (177 µmol/L) measured before surgery. This reflects significant renal impairment, which is independently associated with cardiovascular morbidity and mortality. Patients with chronic kidney disease frequently have accelerated atherosclerosis, electrolyte abnormalities, and impaired volume regulation.

Study details

Design: Prospective cohort study at Brigham and Women's Hospital, Boston. The derivation cohort consisted of 2,893 patients and the validation cohort of 1,422 patients, all aged ≥ 50 years undergoing elective major noncardiac surgery.
Population: Adults ≥ 50 years undergoing elective major noncardiac surgery with an expected hospital stay of ≥ 2 days. Excluded: emergency surgery, patients under age 50, and surgeries with expected stay < 2 days.
Outcome: Major cardiac complications, defined as myocardial infarction, pulmonary edema, ventricular fibrillation or primary cardiac arrest, and complete heart block.
Derivation: Multivariate logistic regression identified six independent predictors from a pool of candidate variables, each assigned 1 point based on comparable odds ratios.
Performance: The RCRI demonstrated good discrimination with an AUC of 0.77 in the validation cohort. Subsequent external validations have reported AUCs ranging from 0.62 to 0.87 depending on the patient population and definition of cardiac events.

ACC/AHA guideline integration

The 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery incorporates the RCRI as a first-step risk stratification tool in the stepwise approach to perioperative cardiac assessment:

RCRI 0 (risk < 1%): Proceed to surgery without further cardiac testing.
RCRI ≥ 1 (risk ≥ 1%): Assess functional capacity. If functional capacity is ≥ 4 METs, proceed to surgery. If functional capacity is poor (< 4 METs), unknown, or cannot be determined, consider pharmacologic stress testing if results will change management.

Note: More recent data from the NSQIP-MICA and ACS NSQIP Surgical Risk Calculator may provide more procedure-specific risk estimates in certain populations.

Limitations

Derived in a single-centre population: The original study was performed at a single academic medical centre (Brigham and Women's Hospital). While externally validated in numerous settings, performance varies across populations, surgical procedures, and outcome definitions.
Equal weighting of risk factors: All six criteria receive 1 point despite potentially different magnitudes of risk contribution. For example, CHF and ischemic heart disease may confer different levels of risk in specific surgical contexts.
Does not account for surgery-specific risk: The "high-risk surgery" variable is binary and does not differentiate between varying levels of surgical complexity within high-risk categories.
Age and functional capacity not included: The RCRI does not directly incorporate age or functional capacity, which are important predictors of perioperative cardiac events. The ACC/AHA guidelines recommend assessing functional capacity separately.
Older outcome definitions: The original study used cardiac endpoints from the 1990s. Contemporary definitions of perioperative MI (e.g., using high-sensitivity troponin) may yield different event rates.

Key references

Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100(10):1043-1049.
Fleisher LA, Fleischmann KE, Auerbach AD, et al. 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery. J Am Coll Cardiol. 2014;64(22):e77-e137.
Goldman L, Caldera DL, Nussbaum SR, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med. 1977;297(16):845-850.
Ford MK, Beattie WS, Wijeysundera DN. Systematic review: prediction of perioperative cardiac complications and mortality by the revised cardiac risk index. Ann Intern Med. 2010;152(1):26-35.
Duceppe E, Parlow J, MacDonald P, et al. Canadian Cardiovascular Society Guidelines on Perioperative Cardiac Risk Assessment and Management for Patients Who Undergo Noncardiac Surgery. Can J Cardiol. 2017;33(1):17-32.

Practice caveats

The RCRI was derived in patients aged ≥ 50 undergoing elective major noncardiac surgery. It has not been validated for emergency surgery, ambulatory procedures, or younger patients.
The estimated risk percentages are from the original 1999 validation cohort. Contemporary perioperative cardiac event rates may differ due to advances in surgical techniques, anaesthesia, and perioperative medical management.
The RCRI should be used in conjunction with clinical judgment and the ACC/AHA stepwise algorithm. Functional capacity (≥ 4 METs) is an important modifier of risk not captured by the RCRI alone.
Consider using the ACS NSQIP Surgical Risk Calculator for more procedure-specific risk estimation, particularly when the RCRI may not adequately distinguish risk for a given operation.

The Revised Cardiac Risk Index (RCRI) is a validated clinical tool used to estimate the risk of major cardiac complications in patients undergoing non-cardiac surgery. Introduced by Dr. Lee and colleagues in 1999, the RCRI is an update of the original Goldman Cardiac Risk Index and has become one of the most widely applied perioperative risk assessment models worldwide. It helps clinicians stratify patients, guide pre-operative evaluations, and optimize perioperative management strategies.

The RCRI predicts the risk of perioperative complications such as myocardial infarction, pulmonary edema, ventricular fibrillation, complete heart block, or cardiac death. By identifying high-risk patients, it enables clinicians to implement preventive strategies including beta-blocker therapy, careful anesthetic planning, and closer postoperative monitoring.

RCRI Predictors

The RCRI is based on the presence of six independent predictors. Each positive predictor scores 1 point, with the total score ranging from 0 to 6.

Predictor	Criteria
High-risk surgery	Intraperitoneal, intrathoracic, or suprainguinal vascular procedures
History of ischemic heart disease	Prior myocardial infarction, positive stress test, or typical angina
History of congestive heart failure	Clinical diagnosis, pulmonary edema, or paroxysmal nocturnal dyspnea
History of cerebrovascular disease	Previous stroke or transient ischemic attack (TIA)
Diabetes mellitus requiring insulin therapy	Use of insulin at the time of surgery
Preoperative renal dysfunction	Serum creatinine > 2.0 mg/dL (177 μmol/L)

Interpretation of Scores

The total RCRI score correlates with an estimated risk of major cardiac complications:

0 points: Very low risk; < 1% chance of major cardiac complications
1 point: Low risk; ≈ 1% chance
2 points: Intermediate risk; ≈ 6% chance
≥ 3 points: High risk; > 10% chance

These estimates guide perioperative planning, including whether additional cardiac evaluation (e.g., echocardiography, stress testing) is warranted before surgery.

Clinical Significance

The RCRI has significant impact in perioperative care:

Risk stratification: Provides an objective measure to classify surgical patients into low, intermediate, or high risk for cardiac events.
Guides preoperative testing: Identifies patients who may benefit from non-invasive cardiac evaluation.
Informs perioperative management: Supports decisions about beta-blocker therapy, statins, and anesthetic choices.
Patient counseling: Helps clinicians discuss surgical risks and informed consent with patients and families.
Research and quality improvement: Commonly used in perioperative outcome studies and hospital benchmarking.

Indications for Use

The RCRI should be applied in:

Adults undergoing non-cardiac surgery where cardiac risk is a concern.
Patients with known cardiovascular disease or significant risk factors.
Elective and urgent surgical planning in general, vascular, and thoracic surgery.
Preoperative assessment clinics and perioperative medicine pathways.

Limitations

Despite its value, the RCRI has limitations:

Excludes certain factors: Does not account for obesity, smoking, hypertension, or left ventricular function.
Population-specific validation: Developed primarily in North American cohorts; predictive accuracy may vary internationally.
Limited predictive power in high-risk surgeries: May underestimate risk in extensive vascular procedures or patients with multiple comorbidities.
Static assessment: Provides a snapshot but does not account for dynamic perioperative changes.